Effect of a centrally active angiotensin converting enzyme inhibitor, perindopril, on cognitive performance in chronic cerebral hypo-perfusion rats-Reference-Cited by-同舟云学术

Effect of a centrally active angiotensin converting enzyme inhibitor, perindopril, on cognitive performance in chronic cerebral hypo-perfusion rats

Published:2011-11 Issue: Volume:1421 Page:110-120
ISSN:0006-8993
Container-title:Brain Research
language:en
Short-container-title:Brain Research

Author:

Yamada Koji,Horita Takako,Takayama Makoto,Takahashi Shusuke,Takaba Katsumi,Nagata Yoshinori,Suzuki Nobuyuki,Kanda Tomoyuki

Publisher

Elsevier BV

Subject

Developmental Biology,Clinical Neurology,Molecular Biology,General Neuroscience

Reference53 articles.

1. Perirhinal N-methyl-d-aspartate and muscarinic systems participate in object recognition in rats;Abe;Neurosci. Lett.,2004

2. Angiotensin II inhibits the release of [3H]acetylcholine from rat entorhinal cortex in vitro;Barnes;Brain Res.,1989

3. Angiotensin II inhibits acetylcholine release from human temporal cortex: implications for cognition;Barnes;Brain Res.,1990

4. Angiotensin II disrupts inhibitory avoidance memory retrieval;Bonini;Horm. Behav.,2006

5. Carboxyl-terminal tripeptidyl hydrolysis of substance P by purified rabbit lung angiotensin-converting enzyme and the potentiation of substance P activity in vivo by captopril and MK-422;Cascieri;Mol. Pharmacol.,1984

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Angiotensin-converting enzyme inhibition prevents l-dopa-induced dyskinesia in a 6-ohda-induced mouse model of Parkinson's disease;European Journal of Pharmacology;2024-06

2. The protective effects of Irbesartan in cognitive impairment in hypertension;Aging;2024-03-23

3. Angiotensin Converting Enzyme-2 (ACE-2): A Target for Novel Drug Development;Advances in Biochemistry in Health and Disease;2024

4. The peptide Acein promotes dopamine secretion through clec-126 to extend the lifespan of elderly C. elegans;Aging;2023-12-27

5. Therapeutic Implications of Renin–Angiotensin System Modulators in Alzheimer’s Dementia;Pharmaceutics;2023-09-06